lysergic acid diethylamide has been researched along with Mood Disorders in 5 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
Mood Disorders: Those disorders that have a disturbance in mood as their predominant feature.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our search revealed 12 eligible studies (n = 257; 124 healthy participants, and 133 patients with mood disorders), with data from randomized controlled trials involving psilocybin (n = 8), lysergic acid diethylamide ([LSD]; n = 3), and ayahuasca (n = 1)." | 5.12 | Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants. ( de Manincor, M; Galvão-Coelho, NL; Gonzalez, M; Marx, W; Perkins, D; Sarris, J; Sinclair, J, 2021) |
| "Lysergic acid diethylamide has been found to have anxiolytic effects, whereas 3,4-methylenedioxymethamphetamine (MDMA) has been used effectively to treat post-traumatic stress disorder (PTSD), with Phase III clinical trial evidence." | 2.82 | Psychedelic medicines for mood disorders: current evidence and clinical considerations. ( Day, K; Galvão-Coelho, NL; Perkins, D; Pinzon Rubiano, D; Sarris, J, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sarris, J | 2 |
| Pinzon Rubiano, D | 1 |
| Day, K | 1 |
| Galvão-Coelho, NL | 2 |
| Perkins, D | 2 |
| Marx, W | 1 |
| Gonzalez, M | 1 |
| Sinclair, J | 1 |
| de Manincor, M | 1 |
| Aixalà, M | 1 |
| Dos Santos, RG | 1 |
| Hallak, JEC | 1 |
| Bouso, JC | 1 |
| De Gregorio, D | 1 |
| Enns, JP | 1 |
| Nuñez, NA | 1 |
| Posa, L | 1 |
| Gobbi, G | 1 |
| Rucker, JJ | 1 |
| Jelen, LA | 1 |
| Flynn, S | 1 |
| Frowde, KD | 1 |
| Young, AH | 1 |
4 reviews available for lysergic acid diethylamide and Mood Disorders
| Article | Year |
|---|---|
Psychedelic medicines for mood disorders: current evidence and clinical considerations.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Mood Disorders; Psilocybin; Psychotherapy | 2022 |
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.
Topics: Affect; Banisteriopsis; Depression; Depressive Disorder, Major; Double-Blind Method; Hallucinogens; | 2021 |
d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.
Topics: Animals; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mood Disorders; Psilocybin | 2018 |
Psychedelics in the treatment of unipolar mood disorders: a systematic review.
Topics: Depressive Disorder, Treatment-Resistant; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mood Di | 2016 |
1 other study available for lysergic acid diethylamide and Mood Disorders
| Article | Year |
|---|---|
Psychedelics and Personality.
Topics: Anxiety Disorders; Banisteriopsis; Clinical Trials as Topic; Hallucinogens; Humans; Lysergic Acid Di | 2018 |